扶正康脉饮联合纤溶酶治疗多发性大动脉炎肾动脉狭窄40例  

Clinical Observation on Treatment of Takayasu Arteritis Renal Artery Stenosis with Fuzheng Kangmai Decoction Combined Plasmin in 40 Cases

作　　者：左爱欣[1] 李晓波[1] 杨步军 雷小明[1] 

机构地区：[1]石家庄长城中西医结合医院周围血管科,河北石家庄050035

出　　处：《辽宁中医杂志》2013年第10期2056-2057,共2页Liaoning Journal of Traditional Chinese Medicine

摘　　要：目的:观察中药扶正康脉饮联合纤溶酶治疗多发性大动脉炎肾动脉狭窄的疗效。方法:回顾性总结本院2005年1月—2009年1月收治的40例多发性大动脉炎肾动脉狭窄患者的治疗及复发情况。结果:本组40例患者中除2例双侧肾动脉重度狭窄者造影后出现肾功能不全,治疗效果不佳外,其余病例治疗后均好转,所有病例均每半年复查并随访至今。结论:多发性大动脉炎肾动脉狭窄常出现肾血管性高血压,肾萎缩是多发性大动脉炎累及肾动脉的严重并发症,经过扶正康脉饮联合纤溶酶治疗,可改善肾脏灌注,避免肾萎缩,复发率低。Objective ：To observe the clinical effect of Fuzheng Kangmai Decoction combined plasmin in the treatment of Taka- yasu arteritis renal artery stenosis. Methods ： It reviewed the treatment and recurrence in 40 patients with Takayasu arteritis renal artery stenosis in our hospital from 2005 January to 2009 January. Results ： Among the 40 patients, except 2 cases of bilateral renal arteries with severe stenosis after angiography had renal insufficiency, the remaining cases were improved after treatment. All the cases were followed up every half year. Conclusion ： Takayasu ai^eritis renal artery stenosis often appears with renal hypertension. Renal atrophy is a severe complication of Takayasu arteritis involving renal artery. Fuzheng Kangmai Decoction combined plasmin therapy may improve the renal perfusion, avoid renal atrophy and low recurrence rate.

关 键 词：多发性大动脉炎 肾动脉狭窄 肾血管性高血压 肾萎缩 

分 类 号：R543.5[医药卫生—心血管疾病]